Meta-analysis published

Patients with periodontal disease helped by Prodentis

Olivier Huck at the Department of Periodontology, Dental Faculty, University of Strasbourg in France. 

A systematic review of probiotics as an adjunct to standard treatment of periodontal disease has confirmed the ­effectiveness of Lactobacillus reuteri Prodentis. Prodentis proved to be the only probiotic that was effective for patients with chronic periodontitis.
     The meta-analysis was the first for probiotics in ­periodontal treatment. Only four studies, all with L. reuteri Prodentis, met the criteria for inclusion in the systematic review. Since no other probiotic products qualified, the ­analysis concluded that L. reuteri Prodentis is the only ­effective probiotic. 
     The studies show that Prodentis gives significant pocket depth reductions in moderate and deep dental pockets when used in combination with standard treatment of chronic periodontitis. According to the authors, the results are similar to those noted for other types of adjuncts to treatment of periodontitis, such as systemic antibiotics.

BioGaia year